Evidence map›Paper›PMID 40951335›Full record

ArticleFrontiers in oncology2025

Multi-omics modality completion and knowledge distillation for drug response prediction in cervical cancer.

DongZi Li, Bowei Yan, Kai Liao, Jian Huang, Jing Zhang, YiChen Chen, Jue Zhu, Shuang Zhi, Liping Chen

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

DongZi Li *Department of Gynecology and Obstetrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.
Bowei Yan *Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Kai Liao *The Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.
Jian HuangCollege of Computer Science, Chongqing University, Chongqing, China.
Jing ZhangDepartment of Gynecology and Obstetrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.
YiChen ChenBasic Research Laboratory, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.
Jue ZhuDepartment of Gynecology and Obstetrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.
Shuang ZhiDepartment of Gynecology and Obstetrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.
Liping ChenDepartment of Gynecology and Obstetrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In clinical practice, the development of personalized treatment strategies for cervical cancer is hindered by the limited accuracy of drug response prediction, partly due to missing modalities in multi-omics data. We present MKDR, a deep learning framework that integrates variational autoencoder-based modality completion with knowledge distillation to transfer information from complete omics data to incomplete samples. MKDR-Student achieves state-of-the-art performance On cervical cancer cell lines, with an MSE of 0.0034 (34% lower than Xgboost), R² of 0.8126, and MAE of 0.0431, while maintaining high Spearman (0.8647) and Pearson (0.9033) correlations. Data ablation experiments highlight the contributions of knowledge distillation and modality completion: removing the teacher increases MSE by 23%, and VAE reduces error by 15% with 40% missingness. Interpretability analysis shows balanced feature contributions from gene expression (38%), copy number variation (30%), and mutation data (32%), indicating effective multi-omics learning and integration by the student model. Under limited-input conditions, MKDR's accuracy drops less than 5%, supporting its robustness and potential for clinical application.

Indexed as

cervical cancerdrug response predictionknowledge distillationmodality completionmulti-omics

Identifiers

PMID40951335
PMCPMC12427122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.